Evidence map›Paper›PMID 25485586›Full record

ArticleCell cycle (Georgetown, Tex.)2014

Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations.

James C Garbe, Lukas Vrba, Klara Sputova, Laura Fuchs, Petr Novak, Arthur R Brothman, Mark Jackson, Koei Chin, Mark A LaBarge, George Watts and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Novel immortalized human vocal fold epithelial cell line: In vitro tool for mucosal biology.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  14. Review
  15. Article
  16. The Role of Ubiquitination and SUMOylation in Telomere Biology.Current issues in molecular biology · 2020
    Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

James C Garbea Life Sciences Division ; Lawrence Berkeley National Laboratory ; Berkeley , CA USA.
Lukas Vrba
Klara Sputova
Laura Fuchs
Petr Novak
Arthur R Brothman
Mark Jackson
Koei Chin
Mark A LaBarge
George Watts
Bernard W Futscher
Martha R Stampfer
University of Arizona · USBerkeley College · USLawrence Berkeley National Laboratory · USCase Western Reserve University · USCzech Academy of Sciences, Biology Centre · CZNemocnice České Budějovice · CZUniversity of California, San Francisco · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
Age-related shifts in epithelial lineages and tissue homeostasis in mammary gland 5R01AG040081-05R01AG040081 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI LABARGE, MARK A · 2011 to 2015
$2.3M
HUMAN MAMMARY CELLSR01CA024844 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI STAMPFER, MARTHA R · 1985 to 2002
$1.6M
The role of microenvironment in aging-related phenotypes of breastR00AG033176 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI LABARGE, MARK A · 2010 to 2012
$703k
MAMMARY CELLSR37CA024844 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI STAMPFER, MARTHA R · 1989 to 1997
–
NCI NIH HHS CA23074NCI NIH HHS CA24844NIA NIH HHS R00AG033176NIA NIH HHS R01 AG040081NIA NIH HHS R01AG040081NIEHS NIH HHS ES06694NIEHS NIH HHS P30 ES006694
6 · The paper itself

Abstract

Telomerase reactivation and immortalization are critical for human carcinoma progression. However, little is known about the mechanisms controlling this crucial step, due in part to the paucity of experimentally tractable model systems that can examine human epithelial cell immortalization as it might occur in vivo. We achieved efficient non-clonal immortalization of normal human mammary epithelial cells (HMEC) by directly targeting the 2 main senescence barriers encountered by cultured HMEC. The stress-associated stasis barrier was bypassed using shRNA to p16(INK4); replicative senescence due to critically shortened telomeres was bypassed in post-stasis HMEC by c-MYC transduction. Thus, 2 pathologically relevant oncogenic agents are sufficient to immortally transform normal HMEC. The resultant non-clonal immortalized lines exhibited normal karyotypes. Most human carcinomas contain genomically unstable cells, with widespread instability first observed in vivo in pre-malignant stages; in vitro, instability is seen as finite cells with critically shortened telomeres approach replicative senescence. Our results support our hypotheses that: (1) telomere-dysfunction induced genomic instability in pre-malignant finite cells may generate the errors required for telomerase reactivation and immortalization, as well as many additional "passenger" errors carried forward into resulting carcinomas; (2) genomic instability during cancer progression is needed to generate errors that overcome tumor suppressive barriers, but not required per se; bypassing the senescence barriers by direct targeting eliminated a need for genomic errors to generate immortalization. Achieving efficient HMEC immortalization, in the absence of "passenger" genomic errors, should facilitate examination of telomerase regulation during human carcinoma progression, and exploration of agents that could prevent immortalization.

Indexed as

Cells, CulturedCellular SenescenceChromosome AberrationsCyclin-Dependent Kinase Inhibitor p16Epigenesis, GeneticGenomic InstabilityHistonesHumansKaryotypingMammary Glands, HumanPromoter Regions, GeneticProto-Oncogene Proteins c-mycRNA InterferenceRNA, Small InterferingTelomeraseCyclin-Dependent Kinase Inhibitor p16HistonesProto-Oncogene Proteins c-mycRNA, Small InterferingTelomeraseBaP, benzo(a)pyrenecarcinogenesisc-MycCT, cholera toxinDDR, DNA damage responseDMR, differentially methylated regionsgenomic instabilityHMEC, human mammary epithelial cellshuman mammary epithelial cellsimmortalizationOIS, oncogene-induced senescencep16INK4ap16sh, shRNA to p16INK4APD, population doublingsp, passageRB, retinoblastoma proteinsenescencetelomeraseTTS, transcription start siteX, oxytocin

Identifiers

PMID25485586
PMCPMC4613853
OpenAlexW2151757310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.